CONSULTING AGREEMENTConsulting Agreement • June 7th, 2022 • Voyager Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJune 7th, 2022 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (including the exhibits attached hereto, “Agreement”), is entered into as of June 6, 2022 (“Effective Date”), by and between (i) Voyager Therapeutics, Inc., a Delaware corporation with an office at 64 Sidney Street, Cambridge, MA 02139 (“Voyager”) and (ii) Dr. Glenn Pierce, M.D., Ph.D., with an address of (“Consultant”).